Eryc (Erythromycin Delayed-Release) Patient Information: Side Effects and Drug Images at RxList

Pill Identifier Search

May 27, 2012

Eryc

Impetigo »

What is impetigo? What causes impetigo?

Impetigo (pronounced im-puh-TIE-go) is a contagious, superficial infection of the skin caused by staphylococcus (Staph) and streptococcus (Strep) bacteria. Impetigo is more common in children (especially 2- to 5-year-olds) than in adults. Impetigo is most likely to occur in warm and humid environments and is most commonly spread by close contact (such as family members).

What are the types of impetigo, and what are impetigo symptoms and signs? What does impetigo look like?

There are two kinds of impetigo:

Non-bullous impetigo: This is the common form, caused by both Staph and Strep bacteria. This form initially presents as small red papules similar to insect bites. These lesions rapidly evolve to small blisters and then to pustules that finally scab over with a characteristic honey-colored crust. This entire process takes about one week. These lesions often st...

Read the Impetigo article »

« Previous
1
2
3
4
5
6
7
8
9
10
Next »

Eryc

Adult Skin Problems Slideshow Pictures

How Smoking Affects Your Looks Slideshow Pictures

Weight Gain Shockers Slideshow

font size

ERYC®
(Erythromycin) Delayed-Release Capsules, USP

To reduce the development of drug-resistant bacteria and maintain the effectiveness of ERYC® and other antibacterial drugs, ERYC should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

DRUG DESCRIPTION

ERYC capsules contain enteric-coated pellets of erythromycin base for oral administration. Each ERYC capsule contains 250 mg of erythromycin base. Also contains: lactose NF, povidone USP, FD&C Yellow #6 and other ingredients. The capsule shell contains gelatin NF, titanium dioxide USP, FD&C Yellow #6.

Erythromycin is produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics. It is basic and readily forms salts with acids but it is the base which is microbiologically active. Erythromycin base is (3R *, 4S *, 5S *, 6R *, 7R *, 9R *, 11R *, 12R *, 13S *, 14R *)-4[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6- trideoxy-3-(dimethylamino)-β-D-xylohexopyranosyl]oxy]-oxacyclo-tetradecane-2,10-dione.